ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Sodium hydride → (3R)-tert-butyl 3-(6-(5-bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-3-yl)pyrazin-2-yloxy)piperidine-1-carboxylate

HRID 1529268
印刷

反応式

HRID 1529268 の反応式
[H-].[Na+].[OH:3][C@@H:4]1[CH2:9][CH2:8][CH2:7][N:6]([C:10]([O:12][C:13]([CH3:16])([CH3:15])[CH3:14])=[O:11])[CH2:5]1.[Br:17][C:18]1[CH:19]=[C:20]2[C:24](=[CH:25][CH:26]=1)[N:23]([CH:27]1[CH2:32][CH2:31][CH2:30][CH2:29][O:28]1)[N:22]=[C:21]2[C:33]1[CH:38]=[N:37][CH:36]=[C:35](Cl)[N:34]=1>CN(C=O)C>[Br:17][C:18]1[CH:19]=[C:20]2[C:24](=[CH:25][CH:26]=1)[N:23]([CH:27]1[CH2:32][CH2:31][CH2:30][CH2:29][O:28]1)[N:22]=[C:21]2[C:33]1[N:34]=[C:35]([O:3][C@@H:4]2[CH2:9][CH2:8][CH2:7][N:6]([C:10]([O:12][C:13]([CH3:16])([CH3:15])[CH3:14])=[O:11])[CH2:5]2)[CH:36]=[N:37][CH:38]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

5

反応物 3

HCID 24758Sodium hydrideHCID 1514398(R)-1-Boc-3-hydroxypiperidineHCID 867097585-bromo-3-(6-chloropyrazin-2-yl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole

生成物 1

HCID 67960228(3R)-tert-butyl 3-(6-(5-bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-3-yl)pyrazin-2-yloxy)piperidine-1-carboxylate収率 99%

試薬・触媒・溶媒 1

HCID 6228
Dimethylformamide
溶媒

実験手順

NaH (60% in mineral oil, 0.081 g, 2.032 mmol) was added to a solution of (R)-tert-butyl 3-hydroxypiperidine-1-carboxylate (0.245 g, 1.219 mmol, Astatech, Inc.) in DMF (2.50 mL) at 0° C. The mixture was stirred for 15 min then 5-bromo-3-(6-chloropyrazin-2-yl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole 1c (0.400 g, 1.016 mmol, Pharmacore) was added and the heterogenous mixture was warmed to RT. After 60 min at RT, ice was added and the mixture was extracted with EtOAc (3×). The combined organic layers were dried over anhydrous Na2SO4, filtered and concentrated. The crude material was absorbed onto a plug of silica gel and purified by chromatography through a Redi-Sep pre-packed silica gel column (12 g), eluting with a gradient of 0% to 50% EtOAc in hexane, to provide tert-butyl (3R)-3-((6-(5-bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-3-yl)-2-pyrazinyl)oxy)-1-piperidinecarboxylate (0.562 g, 1.006 mmol, 99% yield) as a light-yellow foam. MS (ESI, pos. ion) m/z: 558.0, 560.0 (M+1).

後処理

  1. waitAfter 60 min at RT
  2. additionice was added
  3. extractionthe mixture was extracted with EtOAc (3×)
  4. dry with materialThe combined organic layers were dried over anhydrous Na2SO4
  5. filtrationfiltered
  6. concentrationconcentrated
  7. customThe crude material was absorbed onto a plug of silica gel
  8. custompurified by chromatography through a Redi-Sep pre-packed silica gel column (12 g)
  9. washeluting with a gradient of 0% to 50% EtOAc in hexane

出典と根拠

ORDレコード
ord-7bf7961db35a46cf8814d7138582318f
出典データセット
uspto-grants-2015_07
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US09090593B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート